RESUMO
The ICH M10 guideline on bioanalytical method validation and sample analysis is being adopted since 2023. However, and inevitably, some paragraphs or requirements remain ambiguous and are open for different interpretations. In support of a harmonized interpretation by the industry and health authorities, the European Bioanalysis Forum organized a workshop on 14 November 2023 in Barcelona, Spain, to discuss unclear and/or ambiguous paragraphs which were identified by the European Bioanalysis Forum community and delegates of the workshop prior to the workshop. This manuscript reports back from the workshop with recommendations and aims at continuing an open scientific discussion within the industry and with regulators in support of a science-driven guideline for the bioanalytical community and in line with the ICH mission - that is, achieve greater harmonization worldwide to ensure that safe, effective and high-quality medicines are developed and registered in the most resource-efficient manner.
Assuntos
Projetos de Pesquisa , Relatório de Pesquisa , RetroalimentaçãoRESUMO
AIM: Recombinant glycoprotein produced in nonhuman mammalian cell lines can be modified with the immunogenic nonhuman sialic N-glycolylneuraminic acid (Neu5Gc). We describe here a validated method for detection of antidrug antibodies against both protein and Neu5Gc-containing glycan epitopes. RESULTS: An electrochemiluminescent method was established with drug conjugates as capture and detection reagents. Rabbit antidrug polyclonal antibodies were used as the positive control for protein moiety-specific antibodies, while chicken anti-Neu5Gc polyclonal antibodies were used as the positive control for antibodies against Neu5Gc glycan epitope. Specificity to Neu5Gc was verified by signal inhibition with bovine γ-globulin that contains Neu5Gc. CONCLUSION: The assay illustrated here discerns the immunogenicity of the protein backbone and the sialic acid Neu5Gc glycan moiety of a recombinant protein containing Neu5Gc.
Assuntos
Glicoproteínas/química , Glicoproteínas/imunologia , Imunoensaio/métodos , Ácido N-Acetilneuramínico/química , Ácidos Neuramínicos/química , Proteínas Recombinantes/química , Proteínas Recombinantes/imunologia , Animais , Especificidade de Anticorpos , HumanosRESUMO
The 8th GCC Closed Forum for Bioanalysis was held in Baltimore, MD, USA on 5 December 2013, immediately following the 2013 AAPS Workshop (Crystal City V): Quantitative Bioanalytical Methods Validation and Implementation--The 2013 Revised FDA Guidance. This GCC meeting was organized to discuss the contents of the draft revised FDA Guidance on bioanalytical method validation that was published in September 2013 and consolidate the feedback of the GCC members. In attendance were 63 senior-level participants, from seven countries, representing 46 bioanalytical CRO companies/sites. This event represented a unique opportunity for CRO bioanalytical experts to share their opinions and concerns regarding the draft FDA Guidance, and to build unified comments to be provided to the FDA.
Assuntos
Técnicas de Química Analítica/normas , Guias como Assunto , Estudos de Validação como Assunto , Biomarcadores/análise , Calibragem , Ligantes , Limite de Detecção , Kit de Reagentes para Diagnóstico , Reprodutibilidade dos Testes , Estados Unidos , United States Food and Drug AdministrationRESUMO
The 5th GCC in Barcelona (Spain) and 6th GCC in San Antonio (TX, USA) events provided a unique opportunity for CRO leaders to openly share opinions and perspectives, and to agree upon recommendations on biomarker bioanalytical method validation.
Assuntos
Bioensaio/normas , Biomarcadores/análise , Calibragem , Cromatografia Líquida de Alta Pressão/normas , Serviços Contratados/organização & administração , Humanos , Espectrometria de Massas em Tandem/normas , Estudos de Validação como AssuntoRESUMO
An open letter written by the Global CRO Council for Bioanalysis (GCC) describing the GCC survey results on stability data from co-administered and co-formulated drugs was sent to multiple regulatory authorities on 14 December 2011. This letter and further discussions at different GCC meetings led to subsequent recommendations on this topic of widespread interest within the bioanalytical community over the past 2 years.
Assuntos
Combinação de Medicamentos , Preparações Farmacêuticas/análise , Tecnologia Farmacêutica/normas , Biomarcadores/análise , Cromatografia Líquida de Alta Pressão/métodos , Estabilidade de Medicamentos , Regulamentação Governamental , Guias como Assunto , Humanos , Espectrometria de Massas em Tandem/métodosAssuntos
Biomarcadores/análise , Técnicas de Química Analítica/normas , Preparações Farmacêuticas/análise , Calibragem , Técnicas de Química Analítica/métodos , Descoberta de Drogas/educação , Europa (Continente) , Humanos , Preparações Farmacêuticas/normas , Controle de Qualidade , Padrões de Referência , Reprodutibilidade dos Testes , Sociedades Científicas , Estudos de Validação como Assunto , Recursos HumanosRESUMO
The 3rd Global CRO Council Closed Forum was held on the 3rd and 4th July 2011 in Guildford, United Kingdom, in conjunction with the 19th International Reid Bioanalytical Forum. In attendance were 21 senior-level representatives from 19 CROs on behalf of nine European countries and, for many of the attendees, this occasion was the first time that they had participated in a GCC meeting. Therefore, this closed forum was an opportunity to increase awareness of the aim of the GCC and how it works, share information about bioanalytical regulations and audit findings from different agencies, their policies and procedures and also to discuss some topics of interest and aim to develop ideas and provide recommendations for bioanalytical practices at future GCC meetings in Europe.